Tongue is the enemy
The craving starts in the mouth. The market decided it starts somewhere else.
Tongue is the enemy. Stomach and body suffer.
The thought has been with me for years. Cravings as a taste-reward. The mouth wants the next bite before the body has finished registering the last one. By the time the stomach gets to weigh in, the cookie is gone.
I wondered, what if we could make the tongue forget taste? I mean, for a bit.
Gymnema
A little digging brought me to gymnema. Gurmar in Hindi. Sugar-destroyer. A leaf used in Ayurvedic medicine for two thousand years, with a quiet party trick. It binds to the sweet receptors on your tongue and shuts them off for about an hour. You eat the cookie. The cookie tastes like a piece of paper. You stop wanting cookies.
The plant is from India. You can find it as churna, capsule, tea, or raw leaf in any decent ayurvedic shop. What you cannot find here, oddly, is the format I had in my head. The mint. The lozenge. The thing you put on your tongue at the moment the craving arrives, between the meal and the mistake.
It felt like a category waiting to happen. Outside-in instead of inside-out. Not a drug rerouting your hunger hormones. Not a pill working its way through your gut. A lozenge. The mouth, where the craving actually starts.
Almost ten years ago, somebody shipped this. Same mechanism. Same plant. Lozenge, gum, oral spray. A patent. Clinical studies in a peer-reviewed journal. Distribution at Vitamin Shoppe and on Amazon. Bloomberg, Allure, Tim Ferriss. Year: 2018.
I had not heard of them.
A little more digging, to find out what happened. Why it never worked.
GLP-1
Cravings, appetite, the science of why we eat past full, the cultural stigma around willpower, the idea that some people are just biologically louder than others when it comes to food. Mainstream. Everywhere. The cravings conversation is one of the defining wellness stories of this decade.
The craving conversation didn’t get attached to taste.
It got attached to GLP-1.
Ozempic. Wegovy. Mounjaro. Zepbound. The pharmaceutical inside-out path. Today, it is one of the largest drug categories in history, and it dragged the entire cravings conversation with it. Now, when somebody talks about appetite control, they’re talking about gut hormones, satiety signals, and what the brain does after a meal. The mouth has been retired from the discussion. Whether it stays that way is something the next decade gets to decide.
The supplement world followed the wave. Search “natural GLP-1 alternative” today, and you get capsules. Multi-ingredient formulas built to mimic, from the inside, what the injection does. Gymnema is often in the blend, somewhere on the list, alongside other things. The leaf is honored. The format isn’t.
The mechanism that started the conversation became a footnote inside a different formula.
So?
I keep asking myself what to make of this. The shelf had the answer for almost ten years. The wave came. The wave picked the other answer.
Maybe the lozenge format never had a chance because nobody wants to put something bitter in their mouth three times a day. Maybe the taste-receptor frame is too small a story next to “drug that rewires your appetite.” Maybe being early just doesn’t matter when the wave finally arrives, because by the time it arrives, it has decided what it’s looking for.
I didn’t go looking for a category. I went looking for an answer to a problem I couldn’t stop thinking about. I found one. Then I found out the world had already considered it briefly and moved on to something stronger, louder, and more expensive.
If the mouth ever comes back into this conversation, it’ll look like something no one would call a supplement. A piece of dark chocolate that does this. A mint at the end of a meal. A drink. A gum. The mechanism hidden inside a ritual people already have, instead of asking them to add a new one.
The wave will probably crest. The question is whether anyone will be ready when the air shifts, or whether the next person to think about cravings as taste-reward will go through the same loop I just went through, find the same shelf, and write the same post.
Tongue is the enemy. Stomach suffers. Probably. But it doesn’t matter what’s true if the wave decides to lift something else.
About SG
I run Dobby Ads, an AI Creative Agency. I tend to overthink. This is where that overthinking goes. Connect with me on LinkedIn.